7/16/25, 12:39 AM ATI Pharmacology Proctor 2025
ATI Pharmacology PROCTORED EXAM
2025\ACTUAL FIANL EXAM \LATEST VERSION
WIT COMPLETE QUESTIONS AND CORRECT
DETAILED ANSWERS \GRADED A+\LATEST
UPDATED
Terms in this set (70)
What is/are the action(s) d. Both A and B
of the drug metformin?
a. Decreases Hepatic a. Decreases Hepatic glucose production and
glucose production and intestinal glucose absorption
intestinal glucose b. Increases sensitivity to insulin
absorption
b. Increases sensitivity to
insulin
c. Short term sedation
d. Both A and
1/25
,7/16/25, 12:39 AM ATI Pharmacology Proctor 2025
When administering the b. This drug is not intended for long term use
drug senna to a patient, a
health care provider must
inform the patient of
which of the following
A. This drug is intended to
lower blood pressure and
is best used in
combination
with other
antihypertensives
b. This drug is not
intended for long term
use
c. The patient must limit
his/her fiber intake
d. Advise patient to
change positions slowly to
limit the risk of
orthostatic hypotension -
When giving digoxin c. Digibind
(Lanoxin) to a patient, the
health care provider
notices
various signs and
symptoms of an overdose.
The health care provider
knows to
give which of the
following to reverse
digoxin toxicity
a. Naloxone
b. Vitamin K
c. Digibind
d. Fluemanzil -
2/25
, 7/16/25, 12:39 AM ATI Pharmacology Proctor 2025
While providing an a. To lower blood
Angiotensin-converting pressure by blocking the conversion of angiotensin I
enzyme (ACE) inhibitor, to vasoconstrictor
the patient angiotensin II
asks
4. what the action of the
drug is. As a health care
provider, you explain that
the
action of an ACE inhibitor
is
a. To lower blood pressure
by blocking the
conversion of angiotensin
I
to vasoconstrictor
angiotensin II
b. To inhibit reabsorption
of sodium back into the
body, ultimately increasing
urine output and lowering
blood pressure
c. To decrease heart rate
and blood pressure by
competing with Beta1 and
Beta2 receptors in the
heart and lungs
d. To lower blood glucose
by stimulating the release
of insulin -
3/25
ATI Pharmacology PROCTORED EXAM
2025\ACTUAL FIANL EXAM \LATEST VERSION
WIT COMPLETE QUESTIONS AND CORRECT
DETAILED ANSWERS \GRADED A+\LATEST
UPDATED
Terms in this set (70)
What is/are the action(s) d. Both A and B
of the drug metformin?
a. Decreases Hepatic a. Decreases Hepatic glucose production and
glucose production and intestinal glucose absorption
intestinal glucose b. Increases sensitivity to insulin
absorption
b. Increases sensitivity to
insulin
c. Short term sedation
d. Both A and
1/25
,7/16/25, 12:39 AM ATI Pharmacology Proctor 2025
When administering the b. This drug is not intended for long term use
drug senna to a patient, a
health care provider must
inform the patient of
which of the following
A. This drug is intended to
lower blood pressure and
is best used in
combination
with other
antihypertensives
b. This drug is not
intended for long term
use
c. The patient must limit
his/her fiber intake
d. Advise patient to
change positions slowly to
limit the risk of
orthostatic hypotension -
When giving digoxin c. Digibind
(Lanoxin) to a patient, the
health care provider
notices
various signs and
symptoms of an overdose.
The health care provider
knows to
give which of the
following to reverse
digoxin toxicity
a. Naloxone
b. Vitamin K
c. Digibind
d. Fluemanzil -
2/25
, 7/16/25, 12:39 AM ATI Pharmacology Proctor 2025
While providing an a. To lower blood
Angiotensin-converting pressure by blocking the conversion of angiotensin I
enzyme (ACE) inhibitor, to vasoconstrictor
the patient angiotensin II
asks
4. what the action of the
drug is. As a health care
provider, you explain that
the
action of an ACE inhibitor
is
a. To lower blood pressure
by blocking the
conversion of angiotensin
I
to vasoconstrictor
angiotensin II
b. To inhibit reabsorption
of sodium back into the
body, ultimately increasing
urine output and lowering
blood pressure
c. To decrease heart rate
and blood pressure by
competing with Beta1 and
Beta2 receptors in the
heart and lungs
d. To lower blood glucose
by stimulating the release
of insulin -
3/25
